Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaiba oil emulsion before restorative treatment in primary molars with dental caries
RBR-3g6q92Phase 1Not yet recruiting
- Sponsor
- Universidade Federal do Amazonas
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of chlorhexidine in carious lesion (2 arms), sponsored by Universidade Federal do Amazonas. Primary endpoint: Hybrid layer morphology on dentin surfaces. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
chlorhexidine
03
Conditions
carious lesion
Beyond the preview
Go deeper on RBR-3g6q92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3g6q92.